TL;DR: The brief says “gentle daily cleanser,” but the selection list can run 40+ raw materials before we even get to actives
TL;DR: Every new raw material that comes through our receiving dock gets evaluated against what we call our RM-C6 screening protocol — six criteria, each with a hard threshold
Key Technical Parameters #
Cleanser formulation is not a single-material problem. The brief says “gentle daily cleanser,” but the selection list can run 40+ raw materials before we even get to actives. Where most projects lose time is not in the bench work — it’s in the material qualification stage, when a well-intentioned ingredient list collides with supplier lead times, regional compliance gaps, or incompatibility data that nobody checked upfront. This guide is built around six selection criteria we apply to every cleanser material before it enters our approved vendor list (AVL), with numeric thresholds that determine go/no-go decisions. Brand segments that benefit most are those developing for multi-market launch — EU, US, and China simultaneously — where a single non-compliant raw material can stall the entire project. The core insight: material selection is a qualification problem, not a chemistry problem. Chemistry is the easy part.
Six Selection Criteria We Apply Before Any Material Enters a Cleanser Formula #
Every new raw material that comes through our receiving dock gets evaluated against what we call our RM-C6 screening protocol — six criteria, each with a hard threshold. Pass all six and the material goes into the cleanser AVL. Fail one and we flag it for review before it touches a formulation bench.
Criterion 1 — Skin Compatibility Index (SCI via patch test, threshold ≥ 0.8)
We run a modified Zein solubility test alongside a 24-hour patch test to generate an internal SCI score. Any surfactant or solubilizer scoring below 0.8 gets bounced unless the brief explicitly calls for a high-performance cleanse where mild-ness is traded off. For reference, sodium lauryl sulfate (SLS) typically scores 0.3–0.4 in our protocol. Sodium cocoyl isethionate (SCI, the ingredient — not to be confused with the score) consistently lands at 0.88–0.92. That gap matters enormously in a sensitive-skin brief.
Criterion 2 — pH Range Compatibility (formulation stability window)
Target formulation pH for most rinse-off cleansers is 4.5–5.5. Any material that requires a working pH outside 4.0–6.0 to remain stable or functional is a formulation liability. Amphoteric surfactants like cocamidopropyl betaine work cleanly across this window. Some botanical extracts we’ve trialed — particularly certain willow bark preparations — show precipitation and activity loss below pH 5.0. That’s not a disqualification on its own, but it’s flagged at selection stage so we don’t discover it at batch three.
Criterion 3 — Preservative Compatibility Score
This is the criterion teams most often skip at selection and regret at stability. We run a 4-week compatibility screen at 40°C between every new incoming material and our three standard preservative systems: phenoxyethanol/ethylhexylglycerin, sodium benzoate/potassium sorbate, and a COSMOS-certified blend. Materials that cause >10% activity drop in any preservative system are flagged Category B. We have had two surfactant lots in 2023 — both from different suppliers, both listed as “preservative-compatible” on their TDS — fail this screen at week three. Neither supplier could explain it.
Criterion 4 — Regulatory Status (EU, US, China simultaneous clearance)
For any material targeting all three markets, we cross-reference against the EU Cosmetics Regulation 1223/2009 Annex II/III restricted list, FDA Cosmetics Guidelines, and NMPA Cosmetic Regulation inventory requirements simultaneously at the selection stage — not at the compliance review stage. The reason we do it here: NMPA requires ingredients to appear on the Cosmetic Ingredient List (INCI Catalog) for standard filing. Materials that are clean in the EU and US but absent from the NMPA catalog add 3–6 months to a China filing. Catching that at material selection costs nothing. Catching it at registration costs everything.
Criterion 5 — Viscosity Contribution and Processing Window
Rinse-off formulas are almost always viscosity-sensitive, and we’ve learned to build predictability at material selection. Specifically, we require supplier-provided viscosity data at our two standard processing temperatures: 25°C and 60°C. If a material shows >50% viscosity swing between those temperatures without a clear re-equilibration profile, it creates mixing inconsistency at the 500kg batch scale. Carbomer and carbomer analogs are the most common offenders. The 100g bench result looks fine. By 300kg, the pump shear history is different, and you can get gel-point migration that ruins texture uniformity. We flag anything with a high shear sensitivity index at this stage.
Criterion 6 — Supplier Source Redundancy (minimum 2 qualified sources)
Single-sourced materials are a supply chain risk we document formally. Any raw material for which we cannot identify at least two qualified suppliers — meaning two sources that have cleared our QC-07 incoming qualification checklist — is tagged as single-source risk (SSR) in the AVL. This doesn’t block the material from use, but it triggers a minimum safety stock requirement and an automatic quarterly review. We’ve had projects stall because a key emollient went on allocation with no alternative qualified. Once. That was enough.
RM-C6 Screening Results: Common Cleanser Materials #
| Material | SCI Score | pH Stability Window | Regulatory Status (EU/US/CN) | SSR Flag |
|---|---|---|---|---|
| Sodium Cocoyl Isethionate | 0.90 | 4.0–7.5 | All clear | No |
| Cocamidopropyl Betaine | 0.82 | 3.5–8.0 | All clear | No |
| Sodium Lauryl Sulfate | 0.35 | 4.0–9.0 | All clear (restricted in EU leave-on) | No |
| Decyl Glucoside | 0.88 | 4.0–8.0 | All clear, COSMOS eligible | Yes (limited CN sources) |
| Sodium Laureth Sulfate (SLES 2EO) | 0.62 | 4.5–8.5 | All clear | No |
| Sodium Lauroyl Sarcosinate | 0.78 | 5.0–7.0 | All clear | Yes |
The table reflects our AVL data as of Q2 2024. Decyl glucoside’s SSR flag in China is not a permanent disqualifier — we’ve worked around it — but it’s a lead time conversation that needs to happen before, not after, you commit to it as a hero ingredient in a China-launch brief.
The pattern here is worth noting: higher mildness doesn’t automatically mean better regulatory position or better supply reliability. Sodium cocoyl isethionate is genuinely the strongest performer across all six criteria in our dataset. That’s why it appears in a large share of our sensitive-skin cleanser projects.
What Goes Wrong When You Skip the Selection Screen #
This is the longest section for a reason. The failure modes below are not theoretical. They’re the categories we see repeatedly in projects that come to us after a previous development cycle failed or stalled.
Failure Mode 1 — The “clean INCI” trap
A brand specifies a botanical-forward surfactant blend marketed for its natural profile — say, a blend of glucosides with a botanical INCI name on the supplier deck. The TDS is beautiful. The sustainability story writes itself. What the TDS doesn’t always flag clearly is that the blend contains residual fatty alcohol fractions that interact with cationic conditioning agents in a combined shampoo-cleanser format. We ran into this on a 2024 project targeting a clean-beauty micellar cleanser. The formula passed 12-week stability at 25°C. At 40°C, we saw a white precipitate by week six that couldn’t be redispersed. The botanical supplier’s technical team was helpful but had no accelerated stability data for that specific combination. We reformulated with a verified single-origin decyl glucoside. It cost four weeks.
This failure is systemic in the botanical surfactant space because supplier marketing data and supplier formulation support data are often built for different audiences. The marketing deck is written for brand buyers. The technical file is written for formulators. They don’t always say the same thing.
Failure Mode 2 — Preservative incompatibility discovered at micro challenge
Criterion 3 exists because of this. We had an incoming lot of a natural rheology modifier — a biosynthetic cellulose derivative from a European supplier — that had passed all our standard incoming checks. It wasn’t until the preservative compatibility screen at week three that we saw phenoxyethanol efficacy drop by 22% compared to the control formula. The mechanism isn’t fully understood, even internally. Our suspicion is competitive adsorption on the cellulose surface, but we haven’t confirmed it analytically. The supplier had no data on this interaction.
The consequence: any cleanser using that rheology modifier at concentrations above 0.6% would likely have failed a standard challenge test per ISO Standards criteria (ISO 11930 microbial challenge). We caught it before formula lock. If we hadn’t been running the 4-week compatibility screen as standard practice, it would have appeared at the challenge test stage — which is 6–8 weeks deeper into the project.
Failure Mode 3 — Viscosity collapse at production scale
This one we flag in every kickoff call now. Lab samples always look right. The issue surfaces when batch size crosses roughly 200kg and the mixing configuration changes from overhead stirrer to recirculating pump or anchor impeller. Certain thickening systems — particularly combinations of HPMC with electrolyte-sensitive carbomer — show a non-linear viscosity response to shear at scale that doesn’t reproduce in a 500g bench batch. The formula reads 12,000–15,000 cP at bench. At 500kg, post-process viscosity settles at 6,000–8,000 cP. Not catastrophic, but outside specification. Then we’re chasing viscosity with a second carbomer addition, and the batch pH shifts, and suddenly the preservative window is narrower than it should be.
The root cause is almost always that the material was selected based on lab-scale viscosity data. The supplier’s application data was generated at small scale too. At the selection stage, we now require pilot-scale viscosity data or a documented scale-up note from the supplier. If they don’t have it, we factor in a viscosity adjustment trial in the project timeline.
Failure Mode 4 — Post-selection regulatory shift
This one is harder to prevent. The SCCS Scientific Opinion landscape has been active on rinse-off categories, particularly around fragrances and certain preservative boosters. A material that was fully compliant at brief stage can shift status during a 12-month development cycle if a new SCCS opinion triggers an Annex III restriction or a limit reduction. We track this through a quarterly regulatory update that feeds back into the AVL. Any material under active SCCS review gets an amber flag in our system, meaning we’ll use it but we advise brand partners that the status is watched. Two materials that were amber in our Q1 2023 tracker had limit changes confirmed by Q3 2024.
The honest framing: you can do everything right at material selection and still get caught by a mid-project regulatory update. The mitigation is to track it, not to pretend it’s solvable at selection stage alone.
Does It Matter Whether the Material Is “Natural” or Synthetic? #
For the RM-C6 screen, not directly. We run the same six criteria regardless of origin. A synthetic material with strong SCI, multi-market compliance, and dual sourcing will clear faster than a “naturally-derived” material with a single supplier and no accelerated stability data for common preservative systems.
Where origin does matter — and this is a real formulation consideration, not marketing — is in batch-to-batch consistency. Our botanical and adaptogen actives experience shows that natural-origin materials carry higher raw material variability: color, odor, and minor constituent drift across crop years. For a cleanser that rinses off in 30 seconds, some of that variability is cosmetically manageable. For a leave-on product, it’s a bigger problem. We adjust incoming specification tightness accordingly — tighter CoA tolerances for natural-origin materials in cleanser applications where color stability matters for the end consumer.
For performance claims, origin is largely irrelevant to our formulation decisions. A 2022 randomized controlled study (n=56, 8 weeks, split-panel design) comparing a glucoside-based cleanser versus an isethionate-based formula found no statistically significant difference in TEWL impact at equivalent cleansing exposure — 22.4 g/m²·h versus 23.1 g/m²·h respectively, within measurement variance. The take from that data: mildness is driven more by the full surfactant system, concentration, and formulation pH than by whether the origin story is natural or synthetic.
How Market Destination Changes the Material Priority Order #
Multi-market launches are where the RM-C6 criteria re-rank. For an EU-only launch, Criteria 1, 2, and 4 carry the most weight — mildness, stability, and compliance. For a China-domestic launch, Criterion 4 becomes the dominant filter because NMPA inventory status determines whether you can even file. For a US mass-market brief, Criterion 6 often rises in importance because supply reliability at volume matters more than marginal mildness gains. Our acid exfoliation technology cleanser briefs — where we’re combining surfactants with AHA/BHA actives — add a seventh informal criterion around acid compatibility and preservative synergy that isn’t in the standard RM-C6 screen, because the interaction matrix is more complex.
This is not a universal answer. Which criteria matter most depends on where you’re selling, what you’re claiming, and what your supply chain looks like. We ask three questions before applying any weighting: What’s the primary market? What’s the on-pack claim? Who is your backup supplier for the top three materials?
Formulation Notes for Brand Partners #
When you brief us on a new cleanser, the first questions aren’t about ingredients. They’re about market and format. Which regulatory markets does this launch in? What’s the primary consumer — sensitive skin, oily/acne-prone, mature? What format — foam pump, gel tube, bar, micellar? Those answers change the RM-C6 weighting before we touch the formula.
The most common brief mistake is specifying a hero ingredient without verifying its NMPA status if China is on the distribution roadmap. We see this regularly with newer INCI-named derivatives — materials that are clean in the EU, uncontested in the US, but simply absent from the current NMPA Cosmetic Ingredient Catalog. Changing a hero material at formula lock stage, after regulatory review has started, is a costly reset. We flag this at kickoff, not at registration.
On timeline: lab samples typically come back in 2–3 weeks from brief receipt assuming AVL materials are specified. Accelerated stability runs 4–8 weeks at 40°C/75% RH. Real-time 24-month stability is initiated concurrently with the accelerated run, so we’re not waiting on it to move forward. Micro challenge testing runs in parallel at 4–6 weeks. The variables that extend timelines are almost always material-sourcing delays or a mid-project market scope change — not formulation complexity.
Frequently Asked Questions #
We want to use a specific botanical extract as a hero ingredient. Can we just add it to an existing base?
A: It depends on the extract’s pH stability and preservative compatibility — two things we screen before adding anything to a base. If the extract hasn’t been through our RM-C6 evaluation, we run a 4-week compatibility trial first. Skipping that step is how precipitates and micro failures appear in week-six stability.
Our target market is China and EU simultaneously. What’s the biggest material-selection risk?
A: NMPA inventory status is the one that catches people. Under NMPA Cosmetic Regulation, any ingredient not listed in the NMPA catalog requires either substitution or a non-standard filing route that adds months. We cross-check this against EU Cosmetics Regulation 1223/2009 Annex restrictions in the same pass — one screen, two markets.
We’ve had a formula pass 12-week accelerated stability before. Why did our previous supplier recommend we re-run everything for this project?
A: Because lot-to-lot variability in natural-origin materials is real, and stability data is batch-specific. A formula stable on lot A of a botanical surfactant can fail on lot B from the same supplier if the minor constituent profile shifts. We’ve seen this with willow bark extract batches that showed pH drift outside the 4.5–5.5 target window depending on harvest year. Stability is not a one-time pass.
What’s your minimum order quantity and how long does the full development cycle take?
A: MOQ for most rinse-off cleansers is 500kg per SKU. Development from brief to approved sample is typically 8–12 weeks, assuming no major material qualification issues and a defined market scope. If NMPA filing is in scope, plan for an additional 3–6 months on the regulatory track, running parallel to production readiness.
Is there a material category we should be thinking about that most brands don’t include in the brief?
A: Packaging material compatibility. We run our RM-C6 screen on the formula, but the one thing we almost never receive upfront is confirmed packaging specs. Surfactant systems at pH below 5.0 can interact with certain HDPE closure grades and some PP tube closures over 6–12 months, causing clouding or seal degradation. We ask for packaging specifications during material selection, not at fill-and-finish — because catching a packaging incompatibility at that stage means a full material re-evaluation.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.